Ovarian Cancer Chemotherapy Toxicities: Management and Patient Well-being
Received Date: Aug 01, 2025 / Published Date: Aug 29, 2025
Abstract
Ovarian cancer chemotherapy, primarily platinum-based and taxane regimens, leads to significant toxicities including gastrointestinal, hematological, and neurological issues. Peripheral neuropathy, myelosuppression, cardiotoxicity, ototoxicity, nephrotoxicity, cognitive impairment, and fatigue are common concerns. Effective management requires a multidisciplinary approach focusing on monitoring, symptom control, patient education, and personalized care to optimize outcomes and quality of life.
Citation: Carter DJ (2025) Ovarian Cancer Chemotherapy Toxicities: Management and Patient Well-being. Current Trends Gynecol Oncol 10: 291
Copyright: 漏 2025 Dr. Jack Carter This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 236
- [From(publication date): 0-0 - Apr 07, 2026]
- Breakdown by view type
- HTML page views: 186
- PDF downloads: 50
